Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection
Canadian Journal of Microbiology · 2024
DOI: 10.1139/cjm-2023-0127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2024. Verfasst von Adrián Rodriguez-Carlos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico. Hauptthemen laut MEDLINE: Immunity, Innate, Mycobacterium Infections, Nontuberculous, Histone Deacetylase Inhibitors, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Consejo Nacional de Ciencia y Tecnologia, Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo, Agencia Estatal de Investigación, Spain.
Abstract (Originalsprache)
Non-tuberculosis infections in immunocompromised patients represent a cause for concern, given the increased risks of infection, and limited treatments available. Herein, we report that molecules for binding to the catalytic site of histone deacetylase (HDAC) inhibit its activity, thus increasing the innate immune response against environmental mycobacteria. The action of HDAC inhibitors (iHDACs) was explored in a model of type II pneumocytes and macrophages infection by Mycobacterium aurum. The results show that the use of 1,3-diphenylurea increases the expression of the TLR-4 in M. aurum infected MDMs, as well as the production of defb4, IL-1β, IL-12, and IL-6. Moreover, we observed that aminoacetanilide upregulates the expression of TLR-4 together with TLR-9, defb4, CAMP, RNase 6, RNase 7, IL-1β, IL-12, and IL-6 in T2P. Results conclude that the tested iHDACs selectively modulate the expression of cytokines and antimicrobial peptides that are associated with reduction of non-tuberculous mycobacteria infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico.
- Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
ORCID-Profile: Bruno Rivas-Santiago
Förderung
- Consejo Nacional de Ciencia y Tecnologia
- Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo
- Agencia Estatal de Investigación, Spain
Zitieren
APA
Rodriguez-Carlos, A., Raúl, A., Jacobo-Delgado, Y. M., Serrano, C. J., Santos-Mena, A., De Jesus-Gonzalez, L. A., Boix, E., & Rivas-Santiago, B. (2024). Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2023-0127
Vancouver
Rodriguez-Carlos A, Raúl A, Jacobo-Delgado YM, Serrano CJ, Santos-Mena A, De Jesus-Gonzalez LA, et al. Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection. Canadian Journal of Microbiology. 2024. doi:10.1139/cjm-2023-0127
BibTeX
@article{RodriguezCarlos2024,
author = {Rodriguez-Carlos, Adrián and Raúl, Anguita and Jacobo-Delgado, Yolanda M and Serrano, Carmen Judith and Santos-Mena, Alan and De Jesus-Gonzalez, Luis Adrian and Boix, Ester and Rivas-Santiago, Bruno},
title = {Drug repositioning identifies histone deacetylase inhibitors that promote innate immunity in non-tuberculous mycobacterial infection},
journal = {Canadian Journal of Microbiology},
year = {2024},
doi = {10.1139/cjm-2023-0127}
}
EUVIMED